The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, SPE2DB25FKYUN, valued at $1,920.05 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of SEREVENT DISKUS 50 MCG 60S pharmaceutical product. This order is part of Dakota Drug's larger Indefinite Delivery Contract (IDC), SPE2DB24D8001, with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which enables the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of November 4, 2024 and does not have a set-aside designation.
Generated 1/31/25, 9:02 AM